Aurobindo Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,661.00
71.5 (4.5%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 21.22 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
58.08
58.08
58.59
58.59
58.59
58.59
Share Warrants & Outstandings
Total Reserve
37,832.89
32,595.24
29,784.21
26,781.26
24,517.39
21,871.28
Shareholder's Funds
37,890.97
32,653.32
29,842.80
26,839.85
24,575.98
21,929.87
Minority Interest
-8.16
-6.39
8.00
12.00
-1.93
-0.88
Long-Term Borrowings
802.75
1,561.65
2,134.90
618.96
249.21
168.49
Secured Loans
798.20
1,159.38
2,134.90
618.96
249.21
168.49
Unsecured Loans
4.55
402.27
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-1,177.59
-989.69
-856.08
-287.88
122.37
121.88
Other Long Term Liabilities
1071.17
307.85
304.42
363.07
359.73
359.79
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
400.41
282.93
225.70
172.72
171.79
157.11
Total Non-Current Liabilities
1,096.74
1,162.74
1,808.94
866.87
903.10
807.27
Current Liabilities
Trade Payables
5,567.27
4,188.85
4,454.16
3,871.31
2,703.05
2,794.68
Other Current Liabilities
5,245.25
3,837.90
3,307.86
3,179.38
3,158.81
2,894.66
Short Term Borrowings
6,873.45
6,380.03
4,180.32
4,242.56
2,123.56
4,803.78
Short Term Provisions
353.04
275.56
256.79
200.53
170.56
171.93
Total Current Liabilities
18,039.01
14,682.34
12,199.13
11,493.78
8,155.98
10,665.05
Total Liabilities
57,018.56
48,492.01
43,858.87
39,212.50
33,633.13
33,401.31
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
28,675.10
23,954.19
22,999.96
17,956.10
14,825.29
13,038.94
Less: Accumulated Depreciation
11,643.25
9,454.41
8,791.85
7,384.42
4,801.21
4,078.81
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
17,031.85
14,499.78
14,208.11
10,571.68
10,024.08
8,960.13
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
3,008.83
3,266.00
2,739.39
4,496.40
2,937.56
2,428.89
Intangible assets under development
2,204.73
1,633.96
1,129.33
893.61
809.64
632.64
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
303.88
251.70
321.65
391.74
618.30
431.22
Long Term Loans & Advances
971.58
865.10
714.55
794.00
575.33
658.44
Other Non Current Assets
414.21
518.60
689.24
153.15
37.52
53.03
Total Non-Current Assets
24,309.81
21,329.55
20,086.95
17,752.59
15,510.44
13,577.80
Current Assets Loans & Advances
Current Investments
747.24
0.01
50.58
151.00
378.85
159.79
Inventories
12,052.94
10,543.72
9,808.23
8,511.23
7,553.85
9,026.57
Sundry Debtors
7,094.37
5,745.93
4,816.74
4,466.38
4,012.26
3,503.28
Cash and Bank
9,870.29
8,235.49
6,278.30
6,084.20
4,190.01
5,474.28
Other Current Assets
362.98
603.55
324.35
458.23
743.04
680.27
Short Term Loans and Advances
2,580.93
2,033.76
2,493.72
1,788.87
1,244.68
979.32
Total Current Assets
32,708.75
27,162.46
23,771.92
21,459.91
18,122.69
19,823.51
Net Current Assets (Including Current Investments)
14,669.74
12,480.12
11,572.79
9,966.13
9,966.71
9,158.46
Total Current Assets Excluding Current Investments
31,961.51
27,162.45
23,721.34
21,308.91
17,743.84
19,663.72
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
57,018.56
48,492.01
43,858.87
39,212.50
33,633.13
33,401.31
Contingent Liabilities
834.37
368.26
311.34
158.53
157.74
140.83
Total Debt
7,676.20
7,941.68
6,315.22
4,861.52
2,372.77
4,972.27
Book Value per share (adjusted)
0
562.21
509.35
458.1
419.46
374.29
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is -3.34% vs 25.75% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 247.95% vs 1.13% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 12.80% vs 4.83% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is 20.73% vs -21.75% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 20.42% vs 14.26% in Mar 2025

Compare Balance Sheet Results of Aurobindo Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
58.08
-98.00
156.08
159.27%
Share Warrants & Outstandings
Total Reserve
37,832.89
37,989.50
-156.61
-0.41%
Shareholder's Funds
37,890.97
37,891.50
-0.53
-0.00%
Minority Interest
-8.16
339.40
-347.56
-102.40%
Long-Term Borrowings
802.75
0.00
802.75
0.00%
Secured Loans
798.20
0.00
798.20
0.00%
Unsecured Loans
4.55
0.00
4.55
0.00%
Deferred Tax Assets / Liabilities
-1,177.59
-672.30
-505.29
-75.16%
Other Long Term Liabilities
1,071.17
1,564.60
-493.43
-31.54%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
400.41
33.80
366.61
1,084.64%
Total Non-Current Liabilities
1,096.74
926.10
170.64
18.43%
Current Liabilities
Trade Payables
5,567.27
3,037.90
2,529.37
83.26%
Other Current Liabilities
5,245.25
6,546.00
-1,300.75
-19.87%
Short Term Borrowings
6,873.45
6,293.50
579.95
9.22%
Short Term Provisions
353.04
870.00
-516.96
-59.42%
Total Current Liabilities
18,039.01
16,747.40
1,291.61
7.71%
Total Liabilities
57,018.56
55,904.40
1,114.16
1.99%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
28,675.10
43,854.30
-15,179.20
-34.61%
Less: Accumulated Depreciation
11,643.25
21,791.00
-10,147.75
-46.57%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
17,031.85
22,063.30
-5,031.45
-22.80%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
3,008.83
1,460.20
1,548.63
106.06%
Intangible assets under development
2,204.73
0.00
2,204.73
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
303.88
1,461.50
-1,157.62
-79.21%
Long Term Loans & Advances
971.58
506.60
464.98
91.78%
Other Non Current Assets
414.21
233.50
180.71
77.39%
Total Non-Current Assets
24,309.81
25,725.10
-1,415.29
-5.50%
Current Assets Loans & Advances
Current Investments
747.24
3,823.30
-3,076.06
-80.46%
Inventories
12,052.94
7,653.40
4,399.54
57.48%
Sundry Debtors
7,094.37
10,123.40
-3,029.03
-29.92%
Cash and Bank
9,870.29
3,348.70
6,521.59
194.75%
Other Current Assets
362.98
749.70
-386.72
-51.58%
Short Term Loans and Advances
2,580.93
4,480.80
-1,899.87
-42.40%
Total Current Assets
32,708.75
30,179.30
2,529.45
8.38%
Net Current Assets (Including Current Investments)
14,669.74
13,431.90
1,237.84
9.22%
Total Current Assets Excluding Current Investments
31,961.51
26,356.00
5,605.51
21.27%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
57,018.56
55,904.40
1,114.16
1.99%
Contingent Liabilities
834.37
48.20
786.17
1,631.06%
Total Debt
7,676.20
6,293.50
1,382.70
21.97%
Book Value per share (adjusted)
0.00
455.96
-455.96
-100.00%
Annual - Borrowings
Borrowings 7,676.20 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -3.34% vs 25.75% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 1,071.17 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 247.95% vs 1.13% in Mar 2025

Annual - Fixed Assets
Fixed Assets 20,040.68 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 12.80% vs 4.83% in Mar 2025

Annual - Investments
Investments 303.88 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 20.73% vs -21.75% in Mar 2025

Annual - Current Assets
Current Assets 32,708.75 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 20.42% vs 14.26% in Mar 2025